FITC Anti-Human CD9 Antibody[HI9a]

The FITC Anti-Human CD9 Antibody [HI9A] is a highly specific and sensitive monoclonal antibody that has been designed for use in a wide range of research applications. This antibody is specifically designed to target the CD9 antigen, which is a cell surface glycoprotein that is expressed on a variety of cell types, including platelets, lymphocytes, and epithelial cells.

The FITC Anti-Human CD9 Antibody [HI9A] has been extensively validated for use in flow cytometry, immunofluorescence, and immunohistochemistry applications. This antibody has been shown to be highly specific for the CD9 antigen, with minimal cross-reactivity with other cell surface markers.

The FITC Anti-Human CD9 Antibody [HI9A] is supplied as a purified, lyophilized powder, which can be reconstituted in a variety of buffer systems for use in a wide range of applications. This antibody has been optimized for use in a variety of research applications, including cell sorting, cell tracking, and cell imaging.

The FITC Anti-Human CD9 Antibody [HI9A] is manufactured to the highest standards of quality and purity, ensuring that researchers can rely on consistent and reproducible results. This antibody is supplied with detailed technical information, including recommended protocols for use in a variety of applications.

Overall, the FITC Anti-Human CD9 Antibody [HI9A] is a highly specific and sensitive monoclonal antibody that is ideal for use in a wide range of research applications. With its high specificity and sensitivity, this antibody is an essential tool for researchers studying the CD9 antigen and its role in a variety of biological processes.